TB Vax ARM meeting: Setting the scene for TB R&D advocacy in 2024
The TB Vaccine Advocacy Roadmap (TB Vax ARM) will hold its first virtual meeting of the year on 14 February 2024 with updates on key news and developments from the field from Treatment Action Group, FIND, and IAVI:
- 2023 TB Research Funding Trends (Mike Frick, Treatment Action Group)
- Reflections from the pre-High-Level Meeting on TB New TB Tools side event (Karishma Saran, FIND)
- 7th Global Forum on TB Vaccines
- Update on the H56:IC31 Phase 2b results
Register for the meeting here.
The TB Vax ARM is a global coalition of TB stakeholders, including TB survivors, civil society organizations, and non-profits, invested in TB vaccine advocacy and research, and seeks to provide coordinated advocacy efforts that are complementary to ongoing TB vaccine R&D and policy efforts. The TB Vax ARM holds regular advocacy meetings with partners from across the world.
